Earnings Feed
Start Free
SAVIENT PHARMACEUTICALS INC·4

Mar 7, 4:47 PM ET

FERRARI LOUIS 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013

Insider Transaction Report

Form 4
Period: 2013-03-05
SAVIENT PHARMACEUTICALS INCSVNT
FERRARI LOUIS
SVP, North American Commerical
Transactions
  • Award

    Option to Purchase Common Stock

    2013-03-05+180,000→ 180,000 total
    Exercise: $0.94Exp: 2023-03-05→ Common Stock (180,000 underlying)
  • Award

    Option to Purchase Common Stock

    2013-03-05+60,200→ 60,200 total
    Exercise: $2.26Exp: 2022-02-01→ Common Stock (60,200 underlying)
  • Award

    Option to Purchase Common Stock

    2012-07-09+150,000→ 150,000 total
    Exercise: $0.56Exp: 2022-07-09→ Common Stock (150,000 underlying)
Holdings

  • Common Stock

    308,459
Footnotes (3)
  • [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
  • [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
  • [F3]These performance options were granted effective July 9, 2012 and vest, if at all, in proportional 25% increments if the closing price of Savient's common stock during any period of 30 consecutive calendar days equals or exceeds certain pre-agreed share prices.

Documents

1 file
  • 4
    rrd373150.xmlPrimary

    FERRARI FORM 4